Impact of cisplatin dose, renal function, and other factors on audiometrically-assessed ototoxicity in more than 1400 adult-onset cancer survivors from The Platinum Study: a multicentre cohort study.

Sanchez VA, Dinh PC Jr, Monahan PO, Fung C, Althouse S, Stump T, Rooker J, Dolan ME, Feldman DR, Hamilton RJ, Pierorazio PM, Martin NE, Huddart R, Kollmannsberger C, Root J, Sesso HD, Weinzierl M, Einhorn LH, Frisina RD, Travis LB

Open source

DOI: 10.1016/j.eclinm.2026.103841
Published: 2026 Apr
Container: EClinicalMedicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2026.103841,
  title = {Impact of cisplatin dose, renal function, and other factors on audiometrically-assessed ototoxicity in more than 1400 adult-onset cancer survivors from The Platinum Study: a multicentre cohort study.},
  author = {Sanchez VA and Dinh PC Jr and Monahan PO and Fung C and Althouse S and Stump T and Rooker J and Dolan ME and Feldman DR and Hamilton RJ and Pierorazio PM and Martin NE and Huddart R and Kollmannsberger C and Root J and Sesso HD and Weinzierl M and Einhorn LH and Frisina RD and Travis LB},
  year = {2026},
  journal = {EClinicalMedicine},
  doi = {10.1016/j.eclinm.2026.103841},
  url = {https://doi.org/10.1016/j.eclinm.2026.103841}
}

RIS

TY  - JOUR
TI  - Impact of cisplatin dose, renal function, and other factors on audiometrically-assessed ototoxicity in more than 1400 adult-onset cancer survivors from The Platinum Study: a multicentre cohort study.
AU  - Sanchez VA
AU  - Dinh PC Jr
AU  - Monahan PO
AU  - Fung C
AU  - Althouse S
AU  - Stump T
AU  - Rooker J
AU  - Dolan ME
AU  - Feldman DR
AU  - Hamilton RJ
AU  - Pierorazio PM
AU  - Martin NE
AU  - Huddart R
AU  - Kollmannsberger C
AU  - Root J
AU  - Sesso HD
AU  - Weinzierl M
AU  - Einhorn LH
AU  - Frisina RD
AU  - Travis LB
PY  - 2026
JO  - EClinicalMedicine
DO  - 10.1016/j.eclinm.2026.103841
UR  - https://doi.org/10.1016/j.eclinm.2026.103841
ER  -

APA

VA, S., Jr, D. P., PO, M., C, F., S, A., T, S., J, R., ME, D., DR, F., RJ, H., PM, P., NE, M., R, H., C, K., J, R., HD, S., M, W., LH, E., RD, F., & LB, T. (2026). Impact of cisplatin dose, renal function, and other factors on audiometrically-assessed ototoxicity in more than 1400 adult-onset cancer survivors from The Platinum Study: a multicentre cohort study.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2026.103841

Source records

pubmed · retrieved 2026-09-26T11:32:58.147Z